Taiwan FDA registration 8ecf5a1c2935cce8b790ae4107e9b594
Halleiro contains lidocaine
TW: 哈蕾柔含利多卡因
Taiwan·Risk Class 3·MAXIGEN BIOTECH INC.·Registered Jan 25, 2019 – Jul 10, 2028ActiveRegistration details
- Analysis ID
- 8ecf5a1c2935cce8b790ae4107e9b594
Company information
- Manufacturer
- MAXIGEN BIOTECH INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- ORIENT EUROPHARMA CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.0007 Hyaluronic acid implants
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Jan 25, 2019
- Expiry Date
- Jul 10, 2028
About this record
Access comprehensive regulatory information for Halleiro contains lidocaine in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 8ecf5a1c2935cce8b790ae4107e9b594 and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is ORIENT EUROPHARMA CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices